Role for immune checkpoint blockade in BRCA2-mutant prostate cancer. This is an ASCO Meeting Abstract from the 2019 ASCO-SITC Clinical Immuno-Oncology Symposium. This abstract does not include a full ...
In recent years, antibodies have become an incredibly popular therapeutic target – with monoclonal antibodies (mAbs) becoming an ever more widely used therapy for a number of diseases, including ...
Comprehensive digital guide to high-throughput screening (HTS) by cytometry, featuring assays, application data, and more Introduction to HTS cytometry and the all-in-one software solution for data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results